Influence of triglycerides on other plasma lipids in middle-aged men intended for hypolipidaemic treatment

Hellenic Journal of Cardiology

Volumn 47, Issue 2, 2006, Pages 78-83

  Kolovou, Genovefa D ^a   Anagnostopoulou, Katherine K ^a   Salpea, Klelia D ^a   Hoursalas, Ioannis S ^a   Petropoulos, Ilias ^a   Bilianou, Helen I ^b   Damaskos, Dimitris S ^a   Giannakopoulou, Vasiliki N ^a   Cokkinos, Dennis V ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

Coronary artery disease; Dyslipidaemia

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DYSLIPIDEMIA; HUMAN; HYPOLIPEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE;

ANTILIPEMIC AGENTS; BIOLOGICAL MARKERS; CHOLESTEROL; CHOLESTEROL, HDL; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; PROGNOSIS; TRIGLYCERIDES;

EID: 33646893463     PISSN: 10117970     EISSN: 10117970     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Stamler J, Wentworth D, Neaton JD, for the MRFIT RESEARCH GROUP: Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 352222 primary screeners of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256: 2823-2828.
2. The Scandinavian Simvastatin Survival Study Group: Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
3. Kolovou GD, Cokkinos DV: Low serum levels of high-density lipoprotein cholesterol and hypolipidaemic treatment. Curr Med Res Opin 2002; 18: 265-268.
4. Foody JM, Pearce GL, Ferdinand FD, et al: HDL predicts survival in Post-CABG men: 20-year experience from The Cleveland Clinic Foundation. Circulation 2000; 102: III90-94.
5. Anonymous: Hypertriglyceridemia and vascular risk: Report of a Meeting of Physicians and Scientists, University College London Medical School. Lancet 1993; 342: 781-787.
6. Sacks FM; Expert Group on HDL-C: The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations. Am J Cardiol 2002; 90: 139-143.
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
8. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of the low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
9. Castelli WP: The triglyceride issue: a view from Framingham. Am Heart J 1986; 112: 432-437.
10. Jeppesen J, Hein HO, Suadicani P, et al: High triglycerides/low-high density lipoprotein cholesterol, ischemic electrocardiogram changes, and risk of ischemic heart disease. Am Heart J 2003; 145: 103-108.
11. Wilson PW, Kannel WB, Anderson KM: Lipids, glucose intolerance and vascular disease: the Framingham study. Monogr Atheroscler 1985; 13: 1-11.
12. Teno S, Uto Y, Nagashima H, et al: Association of postprandial hypertriglyceridemia and carotid intima media thickness in patients with type 2 diabetes. Diabetes Care 2000; 23: 1401-1406.
13. Reaven GM: Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
14. Jeppesen J, Hein HO, Suadicani P, et al: Relation of high TG-low HDL-C and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Biol 1997; 17: 1114-1120.
15. Soro A, Jauhiainen M, Ehnholm C, et al: Determinants of low HDL levels in familial combined hyperlipidemia. J Lipid Res 2003; 44: 1536-1544.
16. Kolovou G, Daskalova D, Anagnostopoulou K, et al: Postprandial hypertriglyceridaemia in patients with Tangier disease. J Clin Pathol 2003; 56: 937-941.
17. Le NA, Ginsberg HN: Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high-density lipoprotein cholesterol. Metabolism 1988; 37: 614-617.
18. Lamarche B, Rashid S, Lewis GF: HDL metabolism in hypertriglyceridemic states: an overview. Clin Chim Acta 1999; 286: 145-161.
19. Patsch JR, Prasad S, Gotto AM Jr, et al: High-density lipoprotein2: relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia and to the activities of lipoprotein lipase and hepatic lipase. J Clin Invest 1987; 80: 341-347.
20. Gotto AM Jr, Patsch JR, Yamamoto A: Postprandial hyperlipidemia. Am J Cardiol 1991, 68: 11A-12A
21. Murakami T, Michelagnoli S, Longhi R, et al: Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol 1995; 15: 1819-1828.
22. Kolovou G, Anagnostopoulou K, Pilatis N, et al: Fasting serum triglyceride and high-density lipoprotein cholesterol levels in patients intended to be treated for dyslipidemia. Vasc Health Risk Manage 2005; 1: 155-161.
23. Kolovou GD, Anagnostopoulou KK, Cokkinos DV: Pathophysiology of dyslipidaemia in the metabolic syndrome. Postgrad Med J 2005; 81: 358-366.
24. Ellison RC, Zhang Y, Qureshi MM, et al: Lifestyle determinants of high-density lipoprotein cholesterol: the National Heart, Lung, and Blood Institute Family Heart Study. Am Heart J 2004; 147: 529-535.
25. Goff DC Jr, D'Agostino RB Jr, Haffner SM, et al: Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism 2005; 54: 264-270.
26. De Oliveirae Silva ER, Kong M, Han Z, et al: Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females. J Lipid Res 1999; 40: 1211-1221.
27. Gordon DJ, Probstfield JL, Garrison RJ, et al: High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American Studies. Circulation 1989; 79: 8-15.
28. Hulley SB, Rosenman RH, Bawol RD, et al: Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med 1980; 302: 1383-1389.
29. Austin MA: Plasma triglycerides and coronary heart disease. Atheroscler Thromb 1991; 11: 2-14.
30. Lamarche B, Després JP, Moorjani S, et al: Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec Cardiovascular Study. Atherosclerosis 1996; 119: 235-245.
31. Goldbourt U, Yaari S, Medalie JH: Isolated low HDL-C as a risk factor for coronary heart disease mortality: A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol 1997; 17: 107-113.
32. Maron DJ: The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease. Am J Cardiol 2000, 86: 11L-14L.
33. Fumeron F, Betoulle D, Luc G, et al: Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high-density lipoprotein and the risk of myocardial infarction. J Clin Invest 1995; 96: 1664-1671.
34. Kauma H, Savolainen MJ, Heikkila R, et al: Sex difference in the regulation of plasma high-density lipoprotein cholesterol by genetic and environmental factors. Hum Genet 1996; 97: 156-162.